March 29, 2017 Bio/Pharma/CRO Informatics & Software Mass Spectrometry

SCIEX Announces New Biotransformation Solutions for Routine and Comprehensive Metabolism and Biologic Catabolism Studies

Biotransform solutions use the first commercial software to automate protein catabolite identification and speeds identification of metabolites and catabolites. March 29, 2017 Framingham, MA — SCIEX, a global leader in life science analytical technologies, announced today the latest additions to its growing line of solutions for pharmaceutical drug discovery and development. The Routine Biotransform Solution... Read more

March 13, 2017 Bio/Pharma/CRO Life Science Tools M&A, Partnerships

GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare

Wauwatosa, Wisconsin – 13 March 2017 – Monitoring expectant mothers and their babies before and during childbirth is a vital and at times a complicated task. GE Healthcare is investing in innovations to make it easier. Today, GE Healthcare announced that it is expanding its Maternal-Infant Care business with the acquisition of Monica Healthcare, a... Read more

March 9, 2017 Acad, Gov/Utilities Bio/Pharma/CRO Industrial M&A, Partnerships

VWR Signs European Distribution Agreement for J.T.Baker® and Macron Fine Chemicals™ Laboratory Pharmaceutical and Production Chemistries

Radnor, PA – March 9, 2017 – VWR (NASDAQ: VWR), the leading global independent provider of products and service solutions to laboratory and production customers, is excited to announce an agreement with Avantor® Performance Materials, LLC. This agreement will allow VWR to distribute Avantor’s beaker-to-bulk portfolio of J.T.Baker® and Macron Fine Chemicals™ brand laboratory and... Read more

March 1, 2017 Bio/Pharma/CRO Product Launch

GE Healthcare expands MRI contrast media product range in Europe with launch of macrocyclic agent Clariscan

VIENNA, AUSTRIA – 1 March, 2017 – Growing its range of magnetic resonance imaging (MRI) contrast media options available to patients and radiologists, GE Healthcare today announced the launch of Clariscan™ (gadoteric acid) at the European Congress of Radiology (ECR) 2017 meeting. Clariscan is a gadolinium-based contrast agent (GBCA) designed to support effective visualisation of... Read more

February 7, 2017 Bio/Pharma/CRO M&A, Partnerships

Austrian Centre of Industrial Biotechnology and GE Healthcare establish a cell line engineering collaboration

CHALFONT ST. GILES, UK and GRAZ/WIEN, AUSTRIA – 7 February 2017 –  The Austrian Centre of Industrial Biotechnology (acib) and GE Healthcare are introducing a cell line engineering research collaboration to bring increased productivity to biomanufacturers. The goal of the three-year partnership is to explore and identify new tools and methods to modify and optimize... Read more

February 2, 2017 Bio/Pharma/CRO M&A, Partnerships

Arven Pharmaceuticals selects GE Healthcare’s FlexFactory to improve Turkish and regional access to biopharmaceuticals

CHALFONT ST. GILES, UK and ISTANBUL, TURKEY– 2 February 2017 – Arven Pharmaceuticals, a Toksoz Group Company, has selected GE Healthcare’s FlexFactory manufacturing platform to expand production capacity at its facility in Kirklareli, Turkey. With this expanded capacity, Arven will support local healthcare needs by bringing biopharmaceuticals to the Turkish and surrounding markets faster, whilst... Read more

January 30, 2017 Bio/Pharma/CRO Clinical Research/Diagn.

Announcement on submission of the Clinical Trial Plan Notification for phase II clinical trial of Oncolytic virus HF10 in Japan

2017 2017/01/30 Announcement on submission of the Clinical Trial Plan Notification for phase II clinical trial of Oncolytic virus HF10 in Japan Kusatsu/Shiga, Japan — January 30, 2017 — Takara Bio Inc. (Takara Bio), today announced that the Clinical Trial Notification was submitted to PMDA (Pharmaceuticals and Medical Devices Agency; Japanese regulatory agency) to conduct... Read more

January 29, 2017 Bio/Pharma/CRO Lab Top-10 Life Science Tools M&A, Partnerships

10x Genomics Collaborates with PerkinElmer to Jointly Offer Automated Next Generation Sequencing Solutions to Researchers

Combines award-winning Chromium™ System from 10x Genomics with PerkinElmer’s state-of-the-art automation solutions PLEASANTON, Calif., January 9, 2017 – 10x Genomics, Inc., a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced they and PerkinElmer, Inc. will jointly offer automated next-generation sequencing (NGS) solutions. PerkinElmer’s automation solutions increase both the throughput... Read more

January 24, 2017 Bio/Pharma/CRO Clinical Research/Diagn.

Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of NY-ESO-1・siTCR gene therapy in Japan

2017 2017/01/24 Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of NY-ESO-1・siTCR gene therapy in Japan Kusatsu/Shiga, Japan — January 24, 2017 — Takara Bio Inc. (Takara Bio), today announced that it has submitted the Clinical Trial Notification for regenerative medicines to PMDA (Pharmaceuticals and Medical Devices Agency), Japanese... Read more